Ocean Diagnostics completed a 110‑patient pilot showing its rapid sepsis identification test matched conventional blood culture results at 100% and detected additional pathogens missed by culture; the company plans clinical trials ahead of CE marking and eventual FDA clearance. Ocean’s workflow uses high‑volume sample prep, pan‑bacterial PCR, nanopore sequencing and a 1,000‑pathogen database to deliver results in ~5 hours, with a goal of 3.5 hours commercially. Separately, researchers published a thermally programmed one‑pot CRISPR assay in Nature Communications designed for on‑site viral surveillance, combining thermal control and CRISPR recognition to enable rapid, sensitive detection outside central labs. Together, the studies highlight parallel efforts to compress time‑to‑answer for infectious disease diagnostics using molecular and sequencing approaches.